
MLKL-IN-2
MLKL-IN-2
Catalog No. M35245
MLKL-IN-2 is an MLKL inhibitor with potential tumorigenic activity for the study of cellular necrosis-related diseases.
Size | Price / USD | Stock | Quantity |
2MG | 128 | Get Quote |
![]() ![]() |
5MG | 188 | Get Quote |
![]() ![]() |
10MG | 312 | Get Quote |
![]() ![]() |
25MG | 625 | Get Quote |
![]() ![]() |
50MG | 984 | Get Quote |
![]() ![]() |
100MG | 1485 | Get Quote |
![]() ![]() |
200MG | 2007 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMLKL-IN-2
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Sáez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1.
molnova catalog



related products
-
GW 806742X
A small molecule MLKL (Mixed Lineage Kinase Domain-Like) interactor that binds the MLKL pseudokinase domain (Kd=9.3 uM).
-
Necrosulfonamide
A small molecule covalent inhibitor of mixed lineage kinase domain like protein (MLKL) that specifically blocks necrosis downstream of RIP3 activation.
-
Necrosulfonamide(b)
Necrosulfonamide is a novel inhibitor of MLKL.